Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 17, 2021

Total Value: $522M (100.0% shares, 0.0% debt)

Holdings (32)

SPDR SER TR 20.8%
Value $109M Shares 800,000 Est. Cost Unrealized
AVIR ATEA PHARMACEUTICALS INC 10.7%
Value $55.8M Shares 903,688 Est. Cost $32.23 Unrealized +109.6%
MEDAVAIL HOLDINGS INC 7.8%
Value $40.89M Shares 2,920,780 Est. Cost $15.05 Unrealized
CEREVEL THERAPEUTICS HLDNG I 4.6%
Value $23.73M Shares 1,728,590 Est. Cost $16.58 Unrealized
SYROS PHARMACEUTICALS INC 4.5%
Value $23.49M Shares 3,139,895 Est. Cost $10.32 Unrealized
FATE FATE THERAPEUTICS INC 4.3%
Value $22.26M Shares 270,000 Est. Cost $63.35 Unrealized +51.3%
NTRA NATERA INC 4.2%
Value $22.14M Shares 218,000 Est. Cost $87.13 Unrealized +25.8%
NUVB NUVATION BIO INC 4.0%
Value $20.9M Shares 2,000,000 Est. Cost $11.18 Unrealized 0.0%
NTLA INTELLIA THERAPEUTICS INC 3.5%
Value $18.06M Shares 225,000 Est. Cost $36.31 Unrealized +84.8%
RGEN REPLIGEN CORP 3.1%
Value $16.04M Shares 82,500 Est. Cost $181.94 Unrealized +12.7%
COGT UNUM THERAPEUTICS INC 2.7%
Value $14.25M Shares 1,622,591 Est. Cost $10.99 Unrealized -12.4%
IOVA IOVANCE BIOTHERAPEUTICS INC 2.5%
Value $12.88M Shares 406,986 Est. Cost $39.90 Unrealized +3.9%
VRDN VIRIDIAN THERAPEUTICS INC 2.2%
Value $11.38M Shares 680,768 Est. Cost $18.72 Unrealized 0.0%
ITEOS THERAPEUTICS INC 2.1%
Value $11.03M Shares 322,794 Est. Cost $33.82 Unrealized
ESSA PHARMA INC 2.0%
Value $10.55M Shares 363,185 Est. Cost $25.37 Unrealized
ORIC ORIC PHARMACEUTICALS INC 1.9%
Value $10.12M Shares 413,061 Est. Cost $28.69 Unrealized +10.1%
CUREVAC N V 1.9%
Value $10.06M Shares 110,000 Est. Cost $91.46 Unrealized
APLS APELLIS PHARMACEUTICALS INC 1.9%
Value $9.869M Shares 230,000 Est. Cost $42.30 Unrealized +11.9%
BOLT BIOTHERAPEUTICS INC 1.8%
Value $9.469M Shares 287,725 Est. Cost $32.91 Unrealized
APTOSE BIOSCIENCES INC 1.6%
Value $8.42M Shares 1,409,150 Est. Cost $4.38 Unrealized
OLINK HLDG AB 1.4%
Value $7.2M Shares 200,000 Est. Cost $36.00 Unrealized
ARVN ARVINAS INC 1.3%
Value $6.891M Shares 104,253 Est. Cost $36.20 Unrealized +111.3%
CSTL CASTLE BIOSCIENCES INC 1.3%
Value $6.846M Shares 100,000 Est. Cost $54.21 Unrealized +38.7%
ITAMAR MED LTD 1.3%
Value $6.552M Shares 273,569 Est. Cost $19.86 Unrealized
FDMT 4D MOLECULAR THERAPEUTICS IN 1.2%
Value $6.507M Shares 150,000 Est. Cost $41.28 Unrealized +7.3%
SPRY SILVERBACK THERAPEUTICS INC 1.1%
Value $5.61M Shares 128,572 Est. Cost $33.40 Unrealized +41.7%
ADICET BIO INC 1.1%
Value $5.559M Shares 425,000 Est. Cost $13.08 Unrealized
FREELINE THERAPEUTICS HLDGS 1.0%
Value $5.027M Shares 408,726 Est. Cost $18.26 Unrealized
IMVT IMMUNOVANT INC 0.8%
Value $4.17M Shares 260,000 Est. Cost $26.37 Unrealized 0.0%
ORCHARD THERAPEUTICS PLC 0.8%
Value $3.974M Shares 547,427 Est. Cost $4.32 Unrealized
LUNG PULMONX CORP 0.5%
Value $2.696M Shares 58,939 Est. Cost $48.97 Unrealized +17.1%
IDYA IDEAYA BIOSCIENCES INC 0.1%
Value $705K Shares 30,000 Est. Cost $19.31 Unrealized 0.0%